Fact check · Version 1 · Sources checked
“Melanotan II protects you from sun damage or lowers skin cancer risk.”
This guide explains research. It was not independently medically reviewed, and it does not diagnose, prescribe, or recommend treatment.
Misleading
This statement leaves out a limit that changes its meaning.
No trial of any kind has tested sunburn, ultraviolet damage, or skin cancer as an endpoint. The published record runs the other way: melanoma and dysplastic naevus case reports, a review counting four melanomas emerging from existing moles during or shortly after melanotan use, and an approved melanocortin-1 agonist whose label calls for twice-yearly full-body skin examination because it can darken pre-existing naevi.
- What this answer is based on
- No reliable study in people shows the health outcome in this statement.
- Limits of this answer
- All protective or preventive framing, including the comparison with sunbeds. These limits show which substance, product, people, use, place, and time the answer covers. A different product or situation can have a different answer.
- Topic
- What is known and not known about harm, warnings, and safety limits.
Sources for this fact check
Show 4 sources
01Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a reviewPubMed · International Journal of Dermatology · Science review · 201702Melanoma associated with the use of melanotan-IIPubMed · Dermatology · Reference · 201403Melanotan II nasal spray: a possible risk factor for oral mucosal malignant melanoma?PubMed · International Journal of Oral and Maxillofacial Surgery · Reference · 202504SCENESSE (afamelanotide) prescribing informationDailyMed · U.S. National Library of Medicine · Drug label · 2026
- Sources checked by
- Site editor · Editorial review